NovaBay Pharmaceuticals, Inc. Investing cash flow

Investing cash flow of NBY for past 10 years: annual, quarterly and twelve month trailing (TTM) including Investing cash flow growth rates and interactive chart.


Highlights and Quick Summary

  • Investing cash flow for the quarter ending September 30, 2022 was $-80 Thousand (a 900.0% increase compared to previous quarter)
  • Year-over-year quarterly Investing cash flow decreased by -99.33%
  • Annual Investing cash flow for 2021 was $-12 Million (a 46226.92% increase from previous year)
  • Annual Investing cash flow for 2020 was $-26 Thousand (a 36.84% increase from previous year)
  • Annual Investing cash flow for 2019 was $-19 Thousand (a -56.82% decrease from previous year)
  • Twelve month Investing cash flow ending September 30, 2022 was $-12.1 Million (a 0.52% increase compared to previous quarter)
  • Twelve month trailing Investing cash flow increased by 0.56% year-over-year
Trailing Investing cash flow for the last four month:
30 Sep '22 30 Jun '22 31 Mar '22 31 Dec '21
$-12.1 Million $-12.1 Million $-12 Million $-12 Million
Visit stockrow.com/NBY for comprehensive keystats, realtime prices, income statement, balance sheet, cash flow statement with 10 years of data, and state-of-the-art screener.

Historical Investing cash flow of NovaBay Pharmaceuticals, Inc.

Most recent Investing cash flowof NBY including historical data for past 10 years.

Interactive Chart of Investing cash flow of NovaBay Pharmaceuticals, Inc.

NovaBay Pharmaceuticals, Inc. Investing cash flow for the past 10 Years (both Annual and Quarterly)

(All values are in $ million)

Year Q1 Q2 Q3 Q4 Fiscal Year
2022 $-0.08 $-0.01 $-0.02
2021 $-12.0 $-0.02 $-0.0 $-0.03 $-12.05
2020 $-0.02 $-0.01 $-0.03
2019 $0.0 $0.0 $-0.01 $-0.01 $-0.02
2018 $-0.03 $-0.01 $-0.0 $-0.0 $-0.04
2017 $-0.02 $-0.07 $-0.1 $-0.06 $-0.24
2016 $-0.08 $-0.04 $-0.02 $-0.02 $-0.16
2015 $-0.08 $-0.02 $-0.01 $0.02 $-0.09
2014 $1.27 $2.51 $1.14 $-2.32 $2.6
2013 $1.22 $0.91 $-0.04 $-0.69 $1.41
2012 $0.43 $0.99 $-0.52 $0.46 $1.36
2011 $-3.54 $-4.67

Business Profile of NovaBay Pharmaceuticals, Inc.

Sector: Healthcare
Industry: Biotechnology